Functional single-cell analyses of mesenchymal stromal cell proliferation and differentiation using ALDH-activity and mitochondrial ROS content.
Autor: | Refeyton A; Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France; Université de Bordeaux, Bordeaux, France; Inserm Bordeaux U1211, Bordeaux, France., Labat V; Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France; Université de Bordeaux, Bordeaux, France; Inserm Bordeaux U1211, Bordeaux, France., Mombled M; Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France; Genethon, Évry-Courcouronne, France; Inserm, Évry-Courcouronne, France., Vlaski-Lafarge M; Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France; Université de Bordeaux, Bordeaux, France; Inserm Bordeaux U1211, Bordeaux, France., Ivanovic Z; Etablissement Français du Sang Nouvelle Aquitaine, Bordeaux, France; Université de Bordeaux, Bordeaux, France; Inserm Bordeaux U1211, Bordeaux, France. Electronic address: zoran.ivanovic@efs.sante.fr. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cytotherapy [Cytotherapy] 2024 Aug; Vol. 26 (8), pp. 813-824. Date of Electronic Publication: 2024 Apr 10. |
DOI: | 10.1016/j.jcyt.2024.04.003 |
Abstrakt: | Baskground: Previous research has unveiled a stem cell-like transcriptome enrichment in the aldehyde dehydrogenase-expressing (ALDH high ) mesenchymal stromal cell (MStroC) fraction. However, considering the heterogeneity of MStroCs, with only a fraction of them presenting bona fide stem cells (MSCs), the actual potency of ALDH as an MSC-specific selection marker remains an issue. Methods: To address this, the proliferative and differentiation potential of individual ALDH high and ALDH low MStroCs incubated at low oxygen concentrations, estimated to mimic stem cell niches (0.1% O Results: We confirm that a high proliferative capacity and multi-potent MSCs are enriched in the ALDH high MStroC population, especially when cells are cultured at 0.1% O Conclusion: Our study reveals that ALDH expression is not exclusively associated with MSCs. However, cell sorting using combined ALDH expression and ROS content can be utilized to exclude MStroCs lacking stem/progenitor cell properties. Competing Interests: Declaration of Competing Interest The authors have no commercial, proprietary or financial interest in the products or companies described in this article. (Copyright © 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |